Yoga May Boost Cognition, Reduce Depression and Aid Gut Health in Early Alzheimer’s: AIIMS Study

IMT News Desk
IMT News Desk
· 2 min read
AIIMS-led study suggests that yoga may boost cognition, reduce depression, Reduce Depression and Aid Gut Health in people with early Alzheimer’s disease

A new AIIMS-led study suggests that yoga may help improve cognition, reduce depressive symptoms and partially restore healthy gut bacteria in people with early Alzheimer’s disease. The findings add to growing evidence that mind-body interventions may support brain health alongside conventional medical care.

The 12-week structured yoga programme was associated with significant improvements in cognitive performance and mood, according to the report. Researchers also observed changes in the gut microbiome that pointed to a healthier balance of bacteria, raising the possibility that yoga may influence Alzheimer’s outcomes through the gut-brain axis.

The study focused on people with early Alzheimer’s disease, a condition that affects memory, thinking and daily functioning while often causing depression and emotional distress. By examining both neurological and gut-related effects, the researchers aimed to understand whether yoga could offer a broader therapeutic benefit than symptom relief alone.

Although the findings are encouraging, the study does not suggest that yoga can replace standard treatment for Alzheimer’s disease. Instead, it points to yoga as a low-cost, non-invasive supportive therapy that may complement medication, caregiver support and other clinical interventions.

AIIMS researchers say more studies are needed to confirm the results in larger patient groups and over longer periods. Still, the study adds to a growing body of research showing that yoga may have value not just for physical flexibility and stress reduction, but also for brain health, emotional well-being and metabolic balance.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk